Global Blood Cancer Drugs Market [By Blood Cancer Type (Leukemia (Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia), Lymphoma (Hodgkin Lymphoma, Non-Hodgkin Lymphoma (B-Cell Lymphoma, T-Cell Lymphoma)), and Myeloma; By Drugs (Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), and Others); By Treatment Approaches (Chemotherapeutic, mAbs/Targeted Therapies, and Immunotherapeutic); By Region]: Market Size & Forecast, 2017 – 2025
- Published Date: Apr 2018
- Pages: 90
- Format: PDF
- Report ID: PM1238
- Base Year: 2017
- Historical Data: 2015-2016
Request for Discount Pricing
Please fill out the form and get quote for your specific research needs
License and Pricing
Purchase Report Sections
- Regional analysis
- Segmentation analysis
- Industry outlook
- Competitive landscape
Connect With Experts
Suggested Report
- Thyroid Cancer Diagnostics Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Liver Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Astaxanthin Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- Circulating Tumor Cells Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
- CBD Nutraceuticals Market Share, Size, Trends, Industry Analysis Report, 2021 - 2028
Global Blood Cancer Drugs Market Size | Industry Share Report 2025